The challenges of metabolic disorders in Indonesia: focus on metabolic syndrome, prediabetes, and diabetes

  • Ketut Suastika Indonesian Society of Endocrinology, Jakarta, Indonesia; Faculty of Medicine, Universitas Udayana-Sanglah Hospital, Denpasar, Indonesia
DOI: https://doi.org/10.13181/mji.com.205108
Keywords: Commentary
Abstract viewed: 1397 times
PDF downloaded: 1091 times
HTML downloaded: 102 times
EPUB downloaded: 272 times

Abstract

[No abstract available]

Downloads

Download data is not yet available.

References

  1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. https://doi.org/10.1016/S0140-6736(20)30925-9

  2. Institute for Health Metrics and Evaluation. Indonesia [Internet]. Seattle: University of Washington; [cited 2020 Oct 16]. Available from: http://www.healthdata.org/indonesia.

  3. Grundy SM, Brewer Jr HB, Cleeman, JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8. https://doi.org/10.1161/01.CIR.0000111245.75752.C6

  4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of International Diabetes Federation, National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644

  5. Suastika K, Dwipayana P, Saraswati IMR, Gotera W, Budhiarta AAG, Sutanegara IND, et al. Prevalence of obesity, metabolic syndrome, impaired fasting glycemia, and diabetes in selected villages of Bali, Indonesia. J ASEAN Fed Endocr Soc. 2011;26(2):159-62. https://doi.org/10.15605/jafes.026.02.14

  6. Soewondo P, Purnamasari P, Oemardi M, Waspadji S, Soegondo S. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia: the Jakarta primary non-communicable disease risk factors surveillance. Acta Med Indones. 2010;42(4):199-203.

  7. Sigit FS, Tahapary DL, Trompet S, Sartono E, van Dijk KW, Rosendaal FR, de Mutsert R. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr. 2020;12:2. https://doi.org/10.1186/s13098-019-0503-1

  8. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57-70. https://doi.org/10.1016/j.trsl.2017.01.001

  9. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066-72. https://doi.org/10.1161/CIRCULATIONAHA.105.539528

  10. National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia. Basic Health Research (RISKESDAS) 2007. Jakarta: National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia; 2007. Indonesian.

  11. National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia. Basic Health Research (RISKESDAS) 2013. Jakarta: National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia; 2013. Indonesian.

  12. National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia. Basic Health Research (RISKESDAS) 2018. Jakarta: National Institute of Health Research and Development, Ministry of Health of the Republic of Indonesia; 2018. Indonesian.

  13. International Diabetes Federation. IDF diabetes atlas. 9th ed. Brussel: International Diabetes Federation; 2019.

  14. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783-89. https://doi.org/10.1016/S0140-6736(08)60766-7

  15. Sulistiowati E, Sihombing M. Progression of type 2 diabetes mellitus from prediabetes at Bogor, West Java. J Pen Pengemb Pel Kes. 2018;2(1):59-69. Indonesian. https://doi.org/10.22435/jpppk.v2i1.53

  16. Soewondo P. Current practice in the management of type 2 diabetes in Indonesia: results from the International Diabetes Management Practice Study (IDMPS). J Indon Med Assoc. 2011;61(12):474-81.

  17. Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A. The DiabCare Asia 2008 study - Outcomes on control and complications of type 2 diabetic patients in Indonesia. Med J Indones. 2010;19(4):235-44. https://doi.org/10.13181/mji.v19i4.412

  18. Cholil AR, Lindarto D, Pemayun TGD, Wisnu W, Kumala P, Puteri HHS. DiabCare Asia 2012: diabetes management, control, and complications in patients with type 2 diabetes in Indonesia. Med J Indones. 2019;28(1):47-56. https://doi.org/10.13181/mji.v28i1.2931

  19. Soetedjo NNM, McAllister SM, Ugarte-Gil C, Firanescu AG, Ronacher K, Alisjahbana B, et al. Disease characteristics and treatment of patients with diabetes mellitus attending government health services in Indonesia, Peru, Romania and South Africa. Trop Med Int Health. 2018;23(10):1118-28. https://doi.org/10.1111/tmi.13137

  20. Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17(1):150. https://doi.org/10.1186/s12933-018-0787-8

  21. Indonesian Society of Endocrinology. Guidelines for the Management and Prevention of Type 2 Diabetes Mellitus in Adults in Indonesia: Indonesian Society of Endocrinology; 2019.

  22. Indonesian Society of Endocrinology (ISE). Position statement on how to manage patients with diabetes and COVID-19. J ASEAN Fed Endocr Soc. 2020;35(1):49-51. https://doi.org/10.15605/jafes.035.01.03

  23. Stuckey HL, Adelman AM, Gabbay RA. Improving care by delivering the chronic care model for diabetes. Diabetes Manag. 2011;1(1):37-52. https://doi.org/10.2217/dmt.10.9

Published
2020-12-29
How to Cite
1.
Suastika K. The challenges of metabolic disorders in Indonesia: focus on metabolic syndrome, prediabetes, and diabetes. Med J Indones [Internet]. 2020Dec.29 [cited 2024Jul.3];29(4):350-3. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/5108
Issue
Vol. 29 No. 4 (2020): December
Section
Commentary

Copyright (c) 2020 Ketut Suastika

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.